⚕️ The information below is for educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
Consult your healthcare provider before starting any medication or changing your glucose monitoring regimen.
Continuous glucose monitors (CGMs) — led in India by Abbott's FreeStyle Libre — are small sensors worn on the back of the upper arm that measure glucose every few minutes, giving a real-time picture of how your blood sugar moves throughout the day. For people on GLP-1 medications like semaglutide (Ozempic, Rybelsus) or tirzepatide (Mounjaro), a CGM can be a powerful tool to understand how your medication, meals, exercise, and stress interact with your blood sugar.
Yet in India, CGM use among GLP-1 patients remains relatively limited — partly because of cost, partly because of limited awareness, and partly because many patients are unsure how to interpret what they see. This guide explains what CGMs show you that standard blood tests do not, how GLP-1 medications change the patterns you will see on a CGM, and how to use that information to make better decisions.
A standard HbA1c test gives you a 3-month average. A fasting blood glucose shows you one snapshot at one moment. A CGM shows you the full movie.
What CGM reveals that standard tests miss:
Several lower-cost CGMs are entering the Indian market. Verify CDSCO approval before use. The FreeStyle Libre remains the most widely validated option for GLP-1 users.
When you start a GLP-1 medication, you will see characteristic changes on your CGM trace within 1–2 weeks:
GLP-1 medications stimulate insulin secretion in response to food and slow gastric emptying. The result on a CGM is a dramatically flatter, broader curve after meals — instead of a sharp spike to 180–200 mg/dL within 30–45 minutes, you may see a gentler rise to 130–150 mg/dL that peaks later (60–90 minutes) and comes down slowly. This is the medication working as intended.
Most users see fasting glucose drop by 10–30 mg/dL within the first 4 weeks. The CGM will show this as a gradual downtrend in overnight and morning readings.
The "roller coaster" pattern that some diabetics experience — high after meals, crashing later — tends to smooth out significantly on GLP-1 therapy. Lower variability is independently associated with better cardiovascular outcomes.
GLP-1 medications alone rarely cause hypoglycaemia because they only stimulate insulin when glucose is actually high. However, if you are also taking sulfonylureas (glipizide, glimepiride, gliclazide), insulin, or other secretagogues alongside your GLP-1, the combined effect can push glucose too low.
On a CGM, this appears as glucose dropping below 70 mg/dL — especially at night or after exercise. The alarm on FreeStyle Libre 2 will alert you. If this happens, contact your doctor — your non-GLP-1 diabetes medications may need dose reduction.
Track your CGM response to each major meal type for 2 weeks:
Most people discover 1–2 specific meals that cause disproportionate spikes. Modify those meals first. This is more effective than broad dietary restriction.
For Ozempic/Mounjaro (weekly): The medication peaks in effectiveness 48–72 hours after injection. If your CGM shows highest glucose on certain days, injecting 2–3 days before those high-glucose days (weekends, festivals) may help.
For Rybelsus (daily oral): Ensure you are taking on a truly empty stomach. CGM data often reveals whether users who claim to take it correctly are actually getting the absorption benefit — irregular morning glucose control suggests the tablet is being taken with food or drink.
Many patients are told to walk after meals but don't believe it makes a real difference. Your CGM will prove it within the first day. In most people, a 10–15 minute walk within 30 minutes of eating reduces the post-meal peak by 20–40 mg/dL. Seeing this on your own glucose trace is highly motivating.
If your CGM shows glucose rising between 3 and 7 AM despite not eating, you have the dawn phenomenon. This is extremely common among Indian diabetics. Your doctor can use this data to optimise your medication timing — for example, taking Rybelsus slightly later, or adjusting insulin timing if applicable.
Note your glucose on particularly stressful days (exam results, work deadlines, family arguments). Many users are shocked to see glucose rise 30–60 mg/dL from stress alone, even without eating. This data helps your doctor distinguish medication failures from lifestyle-related glucose variability.
| Reading | Target on GLP-1 Therapy |
|---|---|
| Fasting (upon waking) | 80–130 mg/dL |
| Post-meal peak (1–2 hours) | Below 180 mg/dL |
| Overnight (2–3 AM) | Above 70 mg/dL |
| Average (GMI) | Below 154 mg/dL (equivalent to HbA1c < 7%) |
| Time in range (70–180 mg/dL) | 70% or more of the time |
| Time below range (< 70 mg/dL) | Less than 4% of the time |
These are general targets. Your personal targets should be set by your doctor based on your age, duration of diabetes, and other conditions.
1. Panicking at post-meal numbers without context. A reading of 175 mg/dL two hours after a meal is not an emergency — it may be within target. Compare to your baseline before starting GLP-1 to appreciate the improvement.
2. Over-correcting based on single readings. CGMs can occasionally give false readings due to sensor errors, compression (lying on the sensor), or calibration issues. Always confirm unexpected lows or highs with a fingerprick test before acting.
3. Using CGM without sharing data with the doctor. The real value of CGM comes from bringing your Libre reports to your endocrinologist. Most doctors in India now accept digital LibreLink reports. Email them before your appointment.
4. Stopping CGM after the first month. One month of CGM at the start of GLP-1 therapy is useful. Another trial when dose is increased, or when weight loss plateaus, adds further insight. Intermittent use of 2 weeks every 3–4 months is more cost-effective than continuous use for most non-insulin GLP-1 users.
5. Not calibrating meal timing observations correctly. The CGM reads interstitial fluid, which lags 10–15 minutes behind actual blood glucose. A reading at 30 minutes post-meal may not yet show the true peak.
Best candidates for CGM alongside GLP-1:
When CGM is less necessary:
Cost-saving strategy: A single 2-week CGM trial every 3 months (one sensor = ₹3,500–₹4,500) gives most of the insight of continuous monitoring at one-sixth the cost.
Consult your healthcare provider before starting any medication or changing your glucose monitoring regimen.
Q: My doctor has not recommended CGM. Should I buy one anyway? A: You do not need a prescription to buy FreeStyle Libre in India — it is available over the counter. However, the data is most valuable when interpreted with your doctor. If you buy one independently, bring the LibreLink report to your next appointment and ask your doctor to help interpret the patterns.
Q: I am on Rybelsus (oral semaglutide) for weight loss only — no diabetes. Do I need CGM? A: Not routinely. For weight-loss-only GLP-1 users without diabetes, a standard HbA1c every 6 months and periodic fasting glucose is generally sufficient. A 2-week CGM trial is useful if you want to understand which foods affect your glucose, but it is not medically necessary.
Q: Can CGM replace my regular HbA1c blood test? A: No — they measure different things. HbA1c measures 3-month average glucose and is the clinical standard for diabetes monitoring. CGM measures short-term glucose dynamics. Both are complementary. CGM generates a calculated GMI (Glucose Management Indicator) that approximates HbA1c, but the lab test remains more accurate for formal assessments.
Q: The sensor gave a reading of 55 mg/dL at night and I felt fine. Should I trust it? A: Probably not without confirmation. CGM readings below 60–65 mg/dL should always be confirmed with a fingerprick glucometer before taking action. CGMs are less accurate at very low readings. If the fingerprick confirms hypoglycaemia, consume 15g of fast-acting carbohydrate (3 tsp sugar dissolved in water, or 15 glucose tablets) and contact your doctor.
